Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of April 3, 2025 • 7:01 PM ET
As of April 3, 2025 • 7:01 PM ET
Date/Time | Source | News Release |
---|---|---|
03/31/2025 10:02 AM EDT | SeekingAlpha | Curis targets accelerated approval for emavusertib in PCNSL with 12-18 month enrollment timeline |
03/31/2025 09:59 AM EDT | SeekingAlpha | Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript |
03/31/2025 08:01 AM EDT | SeekingAlpha | Curis GAAP EPS of -$1.25, revenue of $3.35M |
03/27/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Thursday, March 27th, 2025 |
03/27/2025 05:30 AM EDT | US Earnings Reports | Expected earnings - Curis Inc. |
03/20/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Thursday, March 20th, 2025 |
03/20/2025 05:30 AM EDT | US Earnings Reports | Expected earnings - Curis Inc. |
03/13/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Thursday, March 13th, 2025 |
03/13/2025 05:31 AM EDT | US Earnings Reports | Expected earnings - Curis Inc. |
03/06/2025 06:00 AM EST | US Earnings Reports | Expected US Company Earnings on Thursday, March 6th, 2025 |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.